Long QTc predicts future cardiac death in stroke survivors

Heart

Volumn 89, Issue 4, 2003, Pages 377-381

  Wong, Kenneth Y K ^a   Mac Walter, R S ^a   Douglas, D ^a   Fraser, H W ^a   Ogston, S A ^a   Struthers, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; FUTUROLOGY; HEART DEATH; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; STROKE; SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0037382430     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.4.377     Document Type: Article

References (25)

1. Dennis MS, Burn JP, Sandercock PA, et al. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993;24:796-800.
2. Elming H, Holm E, Jun L, et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998;19:1391-400.
3. de Bruyne MC, Hoes AW, Kors JA, et al. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998;97:467-72.
4. Okin PM, Devereux RB, Howard BV, et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American indians: the Strong Heart Study. Circulation 2000;101:61-6.
5. Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9.
6. Darbar D, Luck J, Davidson N, et al. Sensitivity and specificity of QTc dispersion for identification of risk of cardiac death in patients with peripheral vascular disease. BMJ 1996;312:874-8.
7. Fei L, Goldman JH, Prasad K, et al. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996;17:258-63.
8. Naas AA, Davidson NC, Thompson C, et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. BMJ 1998;316:745-6.
9. Murray A, McLaughlin NB, Campbell RW. Measuring QT dispersion: man versus machine. Heart 1997;77:539-42.
10. MacWalter RS, Coid DR, Fraser HW, et al. The Dundee stroke register: experience of the first ten years. Scot Med J 1999;44:103-5.
11. Macintyre K, Stewart S, Chalmers J, et al. Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ 2001;322:1152-3.
12. de Bruyne MC, Hoes AW, Kors JA, et al. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam study. Eur Heart J 1999;20:278-84.
13. Veglio M, Borra M, Stevens LK, et al. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM complication study group. Diabetologia 1999;42:68-75.
14. Moreno FL, Villanueva T, Karagounis LA, et al. Reduction in QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 study investigators. Circulation 1994;90:94-100.
15. Sporton SC, Taggart P, Sutton PM, et al. Acute ischaemia: a dynamic influence on QT dispersion. Lancet 1997;349:306-9.
16. Festa A, D'Agostino R, Rautaharju P, et al. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The insulin resistance atherosclerosis study (IRAS). Stroke 1999;30:1566-71.
17. Davey P. QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function. Eur J Heart Failure 2000;2:265-71.
18. Clarkson PB, Naas AA, McMahon A, et al. QT dispersion in essential hypertension. QJM 1995;88:327-32.
19. Pye M, Quinn AC, Cobbe SM. QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br Heart J 1994;71:511-14.
20. CIBIS Investigators. The cardiac insufficiency bisoprorol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
21. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
22. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus revascularization treatment investigators. N Engl J Med 1999;341:70-6.
23. Jermendy G, Toth L, Voros P, et al. Cardiac autonomic neuropathy and QT interval length. A follow-up study in diabetic patients. Acta Cardiol 1991;46:189-200.
24. Veglio M, Giunti S, Stevens LK, et al. Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia: the EURODIAB IDDM complications study group. Diabetes Care 2002;25:702-7.
25. Rana BS, Band M, Ogston SA, et al. Relation of QT dispersion to the number of different cardiac abnormalities in diabetes mellitus. Am J Cardiology (in press).